Mutations of LZTR1 were identified in Noonan syndrome patients with bleeding disorders, and these mutations led to defects in LZTR1-mediated ubiquitination of CHMP1B and, ultimately, impaired vesicle trafficking, resulting in cardiovascular dysfunction [124]. This evidence concerns the gene LZTR1 and hemorrhagic disease.